Hindustan Unilever started looking for alternative channels for importing raw materials which it earlier acquired from China. In a quick move to avoid any further damage to the company amid rising anti-China sentiment, HUL chairman, Sanjiv Mehta said, “We do have imports from China worth ₹429 crore, including raw material and part packing material. And ...

After India has made a mark in marketing the first experimental preventive Covid-19 drug, it is on its way to develop its own indigenous vaccine. After the Central Drugs Standard Control Organisation has allowed Bharat Boitech India (BBIL) to start human trials, Covaxin might become the first Indian vaccine candidate to prevent the spread of ...

The Indian and U.S. technology companies are in dire straits with Trump having tightened the noose over many work visas. However the Indian government and US technology counterparts are trying to reason it out with US President Donald Trump, to rethink the executive order that has put a freeze on many kinds of work visas ...

The Indian nationals are now going ahead to take the judicial route to voice their dissatisfaction over Trump’s recent ban on the H-1B/H4 visa. The law suit has been filed by the immigration law firm Wasden Banias on behalf of 174 Indian nationals including seven minors who have been impacted by this ban. According to ...

The Centre has now given a directive to all ecommerce companies to mention the origins of the products that are being sold to the customers in India. This has been primarily done to earmark those products that are Chinese made. The directive holds good for all e-commerce companies to list the country origin by August, ...

Glenmark Pharma (Glenmark Pharmaceuticals) may have become the first Indian company to market a COVID-19 control drug. It received clearance from the government’s drug regulator to market and manufacturer an oral drug that will treat mild to moderate levels of the virus in Covid-19 disease.   However, the government officials and industry watchdogs have also ...

Glenmark Pharma has become the first Indian company to have received clearance from the government’s drug regulator to market and manufacturer an oral drug that will treat mild to moderate levels of the virus in COVID-19 disease.  The anti viral drug is called Favipiravir and will be marketed by the name Fabiflu that will be ...

Union ministers are rather emotional in the country right now. There is news floating that they intent to ban shops selling Chinese food. Across the nation, there is open boycott and urge to boycott Chinese goods. The country is angry about the way the Chinese troops have picked fights on the Line Of Actual Control ...

According to industry experts, the recent unpleasantness between the Chinese and Indian armed forces is going to have a heavy impact on the Indian manufacturing industry. This is primarily because the tension escalated on the border has led to obvious trade restrictions as well. Experts are of the opinion that this escalating is a ploy ...

In a military stand-off between Indian and Chinese forces on Monday night, both the armies lost a few of their soldiers in the clash at the Galwan valley, located in the mountains of Ladakh. It was the first violent clash between the armies of the Asian giants in the last 45 years. As per the ...